Does IV Vitamin Therapy Work? Does IV Chelation Work?
Alternative medicine clinics are scrambling to add IV services right now. If you've walked into a wellness clinic lately, you've probably seen the menu: vitamin C drips, Myers cocktails, chelation, and newer additions like Plaquex, all promising more energy, cleaner arteries, or a detoxed body.
I wanted to know if any of it actually works. More and more patients tell me they walked into these clinics and got a sales pitch instead of medical care — and a few of them got hurt.
So I went through the clinical evidence, treatment by treatment. Some of it held up better than I expected. Some of it didn't hold up at all.
Here's what I found.
Jump to a section — each link opens the video at that moment.
- 0:00 — Why I'm Investigating Alternative Medicine IV Treatments
- 0:44 — IV Vitamin C: Dosing Trends, Uses, and Fatigue Evidence
- 6:58 — IV Vitamin C Safety, Risks, and Cost
- 11:39 — The Placebo Effect in IV Therapy
- 17:09 — The Myers Cocktail: Claims and the Fibromyalgia Trial
- 23:04 — EDTA Chelation and the Hidden Danger of Lead Exposure
- 30:02 — The TACT Trial: Chelation's Surprising Positive Result
- 34:34 — TACT Criticism and the TACT2 Result
- 40:22 — Plaquex: Investigating the Artery-Cleaning Claims and Cost
- 45:58 — Financial Conflicts of Interest and Why Markers Aren't Outcomes
- 50:04 — Final Takeaways on IV Therapy Safety and Value
Why I'm Investigating Alternative Medicine IV Treatments
More patients are telling me the same thing: they went in for IV therapy and got a sales pitch instead of medical care. A few of them got hurt.
Meanwhile, alternative medicine clinics everywhere are adding IV services. So I decided to go straight to the clinical evidence and find out what's real.
My goal isn't to trash alternative medicine — it's to protect it. I want to teach doctors to practice simple, effective functional medicine, not sell whatever's most profitable.
IV Vitamin C: Dosing Trends, Uses, and Fatigue Evidence
IV vitamin C is the most common IV treatment in alternative medicine, and the doses keep climbing.
A survey of practitioners at complementary medicine conferences tracked what was happening between 2006 and 2008. Average doses were rising, treatments were coming more frequently, and manufacturers' vial sales jumped from 750,000 to 855,000 in that window alone. Most patients were getting it for cancer and infections — fatigue ranked lower, even though fatigue is where the actual evidence is strongest.
I'll say plainly: I don't recommend IV vitamin C for chronic viral infections like Epstein-Barr, CMV, or herpes. In my experience, focusing on those infections doesn't help patients get better.
Fatigue is a different story. A systematic review pooling nine clinical studies and over 700 participants found that three of the four controlled trials showed a significant drop in fatigue scores with IV vitamin C. The five observational studies showed the same pattern. Patients also reported better sleep, less brain fog, improved mood, and less pain — not just less fatigue.
That pattern matters to me clinically. When a treatment improves several unrelated symptoms at once, it's a sign you're treating something real, not just moving a number on a lab report.
One well-designed trial makes the case clearly: 141 healthy office workers were randomized to a single 10-gram IV dose of vitamin C or saline alone. Fatigue scores were significantly better in the vitamin C group at two hours and again the next day. The benefit was concentrated in people who started with low baseline vitamin C levels — not everyone benefits equally, but for the right patient, the effect is real.
IV Vitamin C Safety, Risks, and Cost
IV vitamin C is safe for most people — with a short list of real exceptions.
Across roughly 2,800 patients tracked for adverse events, IV vitamin C carried no more risk than a standard IV bag: some swelling, bruising, or irritation at the injection site, but nothing beyond what any IV brings.
A few groups need to be careful:
Kidney disease. There are documented deaths in patients with significant kidney impairment given high-dose IV vitamin C.
G6PD deficiency. This inherited enzyme deficiency raises the risk of hemolysis — red blood cell breakdown — with high-dose vitamin C. This can become a medical emergency.
History of kidney stones. High-dose vitamin C has been linked to oxalate stone formation.
Electrolyte disturbances. There are case reports of dangerously high sodium levels tied to the fluid and vitamin C load.
Glucometer accuracy. High-dose vitamin C can throw off some blood glucose meters — don't be alarmed by an unusual reading afterward.
Outside of these groups, most people can get high-dose IV vitamin C and feel confident it's safe.
Cost is where it gets trickier. Going rates run $170 to $270 per infusion. Twice-weekly infusions add up to $1,300 a month — and I can't think of many conditions that genuinely need vitamin C that often. If you're fearful or mistrustful of conventional medicine, that's exactly the vulnerability a clinic selling IVs can lean on. Periodic infusions for chronic fatigue may be worth it for some patients. A standing subscription probably isn't.
The Placebo Effect in IV Therapy
The placebo effect may account for as much as 50% of the benefit patients feel from IV therapy.
The more invasive a treatment feels, the stronger that effect tends to be. A capsule creates some expectation. A needle piercing your skin, delivering fluid directly into your bloodstream, creates a lot more.
A post-surgical pain study illustrates this well. Patients recovering from lung surgery — already in significant pain — were divided into groups. Some received a hidden infusion behind a screen with no explanation of what it was; others were told, openly, that what they were receiving was a powerful painkiller. The hidden infusions did essentially nothing on their own. But when patients were told an infusion would relieve their pain, pain scores dropped substantially — even in the group that received nothing but plain IV saline.
That's the placebo effect working through real physiology — the body producing its own endorphins in response to expectation, not the fluid itself. It's a genuine effect. It's also not the same thing as a treatment doing something to your body chemistry.
The Myers Cocktail: Claims and the Fibromyalgia Trial
The Myers cocktail — a mix of B vitamins, calcium, magnesium, and vitamin C given by IV — has been used in alternative medicine for decades, but the evidence behind the blend itself is thin.
One ingredient does have real backing on its own: IV magnesium is a legitimate, well-supported treatment. Emergency medicine uses it to abort asthma attacks in children and to abort migraines, and OB/GYNs use it therapeutically. That part isn't in dispute.
The Myers cocktail as a whole is a different matter. Practitioners claim it helps asthma, fatigue, fibromyalgia, depression, respiratory infections, allergies, and cardiovascular disease — an unusually wide net for one IV bag. Most of that is anecdotal, reported by the same doctors selling the treatment.
When researchers actually tested it in 34 adults with fibromyalgia, both the Myers cocktail group and the placebo group — plain IV fluid — improved. There was no meaningful difference between the two. Both groups saw better pain, mood, and quality of life. The IV itself, or the expectation around it, appears to be doing the work.
I see this constantly in my clinic. Patients arrive with a fibromyalgia diagnosis already convinced that boosting their vitamin C, D, and B-complex will fix their fatigue. It doesn't. Most Americans are not nutrient deficient in a clinically meaningful way, and bumping vitamins — oral or IV — for run-of-the-mill fatigue is almost always a waste of time and money. That's different from a documented deficiency like iron deficiency, which absolutely should be treated.
EDTA Chelation and the Hidden Danger of Lead Exposure
EDTA is a chelator — it binds to positively charged metals like calcium, lead, and cadmium and helps the body excrete them in urine.
Doctors have used it since the 1950s on a simple theory: atherosclerotic plaque contains calcium, so pulling calcium out of the vessel wall might shrink the plaque and prevent heart attacks. Decade by decade, its use has grown, without a clear answer on who should get it or whether it works.
Before getting to that question, it's worth taking a detour into lead — because this is the part of the video I think most people are missing entirely.
There is no safe level of lead in the body. A large population-based cohort study following NHANES participants for over two decades found that even low blood lead levels carry real cardiovascular risk: a blood lead level of just 2 µg/dL corresponded to a 30% higher risk of cardiac death. At 6 µg/dL, all-cause mortality was 70% higher, and ischemic heart disease risk roughly doubled, compared with people near 1 µg/dL. The study's authors estimated that low-level lead exposure accounts for roughly a quarter of a million cardiovascular deaths in the US each year — a toll in the same range as smoking, even though lead's per-person risk is lower, because so much more of the population carries some exposure.
The problem is you won't feel it. Symptoms typically don't show up clinically until levels are far higher — 20 and above. Most of my patients with elevated lead are sitting in the 2–5 range, with no symptoms at all, but real cardiovascular risk. Checking blood lead is a simple, inexpensive test, and I think every adult getting standard cardiovascular screening should get one.
The TACT Trial: Chelation's Surprising Positive Result
In 2013, the largest chelation trial ever run actually came back positive — which surprised almost everyone, including the researchers who designed it to settle the question once and for all.
The Trial to Assess Chelation Therapy (TACT) enrolled 1,708 patients with a prior heart attack and delivered 55,000 total infusions of EDTA plus high-dose vitamin C, weekly for 30 weeks and then 10 more (40 infusions total), against placebo. It ran for five years and tracked hard outcomes: heart attack, stroke, need for a stent, and hospitalization for chest pain.
The chelation group did better. Heart attacks occurred in 6% of the chelation group versus 8% on placebo, stroke was 1.2% versus 1.5%, and hospitalizations were also lower. The benefit was strongest in diabetics and in patients whose original heart attack involved the front wall of the heart — both higher-risk groups. A study published in JAMA, the most conservative journal in the field, appeared to vindicate five decades of alternative medicine practice.
TACT Criticism and the TACT2 Result
The positive result didn't hold up — and a follow-up trial built specifically to retest it in diabetics found nothing.
TACT drew real methodological criticism, published as an editorial in the same JAMA issue. The dropout rate was high — about one in five patients — and skewed toward the placebo group, raising the possibility that unblinding (patients figuring out they weren't getting the "real" treatment and leaving) distorted the results. Most study sites were for-profit infusion clinics run by doctors who sell chelation for a living, not independent academic centers. And the data were examined 11 separate times while the trial was still running — far more than standard practice, and a pattern that can invite bias.
So researchers ran it again, this time focused entirely on the group that benefited most: nearly a thousand patients with diabetes and a prior heart attack, treated with the same 40-infusion protocol and followed for five years. The question was direct: does chelation reduce cardiovascular events in diabetics with heart disease compared to placebo?
The answer was no. TACT2 found no reduction in all-cause mortality, heart attacks, stroke, stent placement, or hospitalization. The dramatic diabetic subgroup benefit from the original trial did not replicate.
Heavy metal chelation should not be used to prevent heart disease. The one legitimate exception is acute lead poisoning, where the FDA has an actual indication for EDTA — but that's a narrow clinical scenario, not routine cardiovascular prevention. If a doctor is marketing EDTA chelation for heart health today, they're using science that's a decade out of date, and it's fair to ask them why.
Plaquex: Investigating the Artery-Cleaning Claims and Cost
Plaquex is marketed as an artery-cleaning treatment. There is no real outcome data behind that claim.
Plaquex is a form of phosphatidylcholine — a phospholipid, the kind of molecule that makes up your cell membranes. Because it's essential to basic cell biology, it's easy to build a plausible-sounding story around it. Whether that story translates into fewer heart attacks or strokes is a completely separate question, and it's the only one that matters.
I spent a full workday trying to track down the studies behind Plaquex's marketing claims. What I found were decades-old citations, several in German and Russian, with no accessible outcome data and no way to verify the numbers behind the graphs on the company's own website. The marketing leans on words like "support," "protect," and "clear arterial buildup" — vague enough to sound impressive without claiming anything a regulator could hold them to.
Here's what the marketing actually shows: it may lower total cholesterol on a lab report. Not fewer heart attacks. Not fewer strokes. A number on a page — and one that reportedly rises again once you stop the infusions, which conveniently keeps patients coming back.
The cost is the real story. At roughly $270 per infusion, a recommended course of 30 infusions runs about $8,000. Sixty infusions — also recommended by some providers — runs $16,000. That's a car. That's a down payment on a house. And it's being sold on citations most of the prescribing doctors have likely never read.
Financial Conflicts of Interest and Why Markers Aren't Outcomes
A lot of doctors in alternative medicine make at least 30% of their income selling supplements, labs, and IVs — and that changes what they're incentivized to recommend.
Imagine your conventional primary care doctor sending you a marketing email offering two-for-one statins. It would be absurd. But walk into many alternative medicine clinics and there's a retail shop up front, an online store, and a doctor who's financially better off the more you buy. Doctors should be doctors, not retailers.
This connects to a bigger principle: moving a number on a lab report is not the same as improving your health. HDL cholesterol is the clearest example. For decades, higher HDL correlated with fewer heart attacks, so drug companies built treatments to raise it directly. A well-run trial gave diabetics on a statin either placebo or fenofibrate, a drug that reliably raises HDL and lowers triglycerides. There was no meaningful difference in heart attacks, strokes, or cardiovascular death between the groups — despite the lipid numbers moving in the "right" direction.
If a treatment can't show it changes outcomes — not markers, outcomes — it's not worth your money or the risk. That standard applies just as much to Plaquex's cholesterol claims as it does to any conventional drug that only moves a lab value. Ask any doctor recommending a treatment: where's the data that this changes what happens to me, not just what my labs say?
Final Takeaways on IV Therapy Safety and Value
Here's where the evidence actually lands, treatment by treatment:
IV placebo effects are real. If the cost is low and the treatment is safe, a placebo benefit from an IV bag isn't nothing — that's a judgment call between you and your doctor.
High-dose IV vitamin C is safe and effective for fatigue, with real evidence behind it, especially in people who start with low levels. (I'm not weighing in on vitamin C for cancer — that's outside my expertise and belongs to oncologists who can properly interpret that separate body of research.)
IV magnesium is a legitimate medical treatment on its own merits.
The Myers cocktail performed no better than placebo in the one controlled trial that's tested it.
Most Americans are not nutrient deficient in a clinically meaningful way — genuine deficiencies deserve treatment, but routine vitamin-bumping for fatigue almost never helps.
IV chelation of heavy metals does not reduce cardiovascular events. The only real exception is acute lead poisoning at very high blood levels, where EDTA has an actual FDA indication.
Plaquex has no outcome data behind it — don't pay to be someone's uncontrolled experiment.
Be wary of any doctor infusing an impressive-sounding molecule into your body unless they can show it changes real outcomes — not triglycerides, not HDL, not "supports vessel longevity." Ask where the data is.
If you've made it this far, share this with someone who's considering IV therapy, or who's already paying for it and hasn't had these questions answered.
Watch the full video here: Does IV Vitamin Therapy Work? Does IV Chelation Work?
Dr. Joe Mather MD, MPH&TM
I am a Medical Doctor practicing in New Orleans, and hold medical licenses from the states of Louisiana and Texas. I am board certified by the American Board of Family Medicine and have been practicing functional medicine for over a decade.
Because so many people struggle for years trying to recover their health, often spending thousands of dollars chasing dead ends, I'm passionate about making functional medicine cost-effective and practical.
I graduated from the Tulane University School of Medicine and the School of Public Health in 2011 and completed my training in Family Practice in 2014. I treat many conditions but have expertise working with chronic GI symptoms, mold and heavy metals and in preventative cardiac care.
Would you like more information, or to schedule an appointment?